Skip to main content
. 2022 Jun 3;40(32):4394–4402. doi: 10.1016/j.vaccine.2022.05.075

Fig. 2.

Fig. 2

Incidence rate ratios and 95% confidence intervals of outcome events in the 21-day risk period after either dose of BNT162b2, CoronaVac, and ChAdOx1 vaccines compared with outcome events in the control period, adjusted for calendar month between 1 February 2021 to 30 September 2021. Abbreviation: NA, not available.